Kay Seden

898 total citations
21 papers, 522 citations indexed

About

Kay Seden is a scholar working on Infectious Diseases, Pediatrics, Perinatology and Child Health and Epidemiology. According to data from OpenAlex, Kay Seden has authored 21 papers receiving a total of 522 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Infectious Diseases, 7 papers in Pediatrics, Perinatology and Child Health and 7 papers in Epidemiology. Recurrent topics in Kay Seden's work include HIV/AIDS drug development and treatment (13 papers), HIV/AIDS Research and Interventions (8 papers) and Pharmacological Effects and Toxicity Studies (6 papers). Kay Seden is often cited by papers focused on HIV/AIDS drug development and treatment (13 papers), HIV/AIDS Research and Interventions (8 papers) and Pharmacological Effects and Toxicity Studies (6 papers). Kay Seden collaborates with scholars based in United Kingdom, Uganda and United States. Kay Seden's co-authors include David Back, Saye Khoo, Laura Dickinson, SH Khoo, Andrew Owen, Marco Siccardi, D.J. Back, Catia Marzolini, Mohammed Lamorde and Sara Gibbons and has published in prestigious journals such as PLoS ONE, Journal of Antimicrobial Chemotherapy and Drugs.

In The Last Decade

Kay Seden

21 papers receiving 506 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kay Seden United Kingdom 14 223 140 85 83 83 21 522
Nancy L. Sheehan Canada 12 212 1.0× 93 0.7× 114 1.3× 21 0.3× 128 1.5× 34 518
Annemie Stewart South Africa 15 218 1.0× 159 1.1× 58 0.7× 15 0.2× 98 1.2× 31 626
Monique M. R. de Maat Netherlands 10 431 1.9× 118 0.8× 85 1.0× 36 0.4× 121 1.5× 15 606
Amanda Corbett United States 16 609 2.7× 260 1.9× 68 0.8× 44 0.5× 151 1.8× 40 1.0k
Cary R. Chrisman United States 7 349 1.6× 267 1.9× 214 2.5× 29 0.3× 90 1.1× 10 687
Charles la Porte Canada 13 478 2.1× 199 1.4× 49 0.6× 21 0.3× 99 1.2× 30 970
Willem L. Blok Netherlands 15 179 0.8× 210 1.5× 28 0.3× 14 0.2× 31 0.4× 32 1.0k
Marc Blockman South Africa 16 145 0.7× 104 0.7× 80 0.9× 10 0.1× 178 2.1× 75 771
Sara Baldelli Italy 23 583 2.6× 178 1.3× 90 1.1× 42 0.5× 331 4.0× 67 1.3k
Cornelis H.W. Koks Netherlands 18 466 2.1× 218 1.6× 190 2.2× 24 0.3× 221 2.7× 38 1.3k

Countries citing papers authored by Kay Seden

Since Specialization
Citations

This map shows the geographic impact of Kay Seden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kay Seden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kay Seden more than expected).

Fields of papers citing papers by Kay Seden

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kay Seden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kay Seden. The network helps show where Kay Seden may publish in the future.

Co-authorship network of co-authors of Kay Seden

This figure shows the co-authorship network connecting the top 25 collaborators of Kay Seden. A scholar is included among the top collaborators of Kay Seden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kay Seden. Kay Seden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Twimukye, Adelline, Phoebe Kajubi, Kay Seden, et al.. (2021). Patient experiences of switching from Efavirenz- to Dolutegravir-based antiretroviral therapy: a qualitative study in Uganda. BMC Infectious Diseases. 21(1). 1154–1154. 22 indexed citations
2.
3.
Bracchi, Margherita, Frank A. Post, Katherine Coyne, et al.. (2019). British HIV Association guidelines for the management of tuberculosis in adults living with HIV 2019. HIV Medicine. 20(S6). s2–s83. 16 indexed citations
4.
Seden, Kay, Marta Boffito, & Saye Khoo. (2017). Drug interactions and the role of pharmacokinetic trials in guiding choices in first-line HIV therapy in low-income and middle-income countries. Current Opinion in HIV and AIDS. 12(4). 377–382. 3 indexed citations
5.
Seden, Kay, Sara Gibbons, Catia Marzolini, et al.. (2017). Development of an evidence evaluation and synthesis system for drug-drug interactions, and its application to a systematic review of HIV and malaria co-infection. PLoS ONE. 12(3). e0173509–e0173509. 28 indexed citations
6.
Seden, Kay, Concepta Merry, Russ Hewson, et al.. (2015). Prevalence and type of drug–drug interactions involving ART in patients attending a specialist HIV outpatient clinic in Kampala, Uganda. Journal of Antimicrobial Chemotherapy. 70(12). dkv259–dkv259. 18 indexed citations
7.
Lewis, Joseph M., et al.. (2015). Managing potential drug-drug interactions between gastric acid-reducing agents and antiretroviral therapy: experience from a large HIV-positive cohort. International Journal of STD & AIDS. 27(2). 105–109. 12 indexed citations
8.
Seden, Kay, Jamie J Kirkham, Tom Kennedy, et al.. (2013). Cross-sectional study of prescribing errors in patients admitted to nine hospitals across North West England. BMJ Open. 3(1). e002036–e002036. 64 indexed citations
9.
Siccardi, Marco, Catia Marzolini, Kay Seden, et al.. (2013). Prediction of drug-drug Interactions Between Various Antidepressants and Efavirenz or Boosted Protease Inhibitors Using a Physiologically Based Pharmacokinetic Modelling Approach. Clinical Pharmacokinetics. 52(7). 583–592. 42 indexed citations
10.
Siccardi, Marco, Adeniyi Olagunju, Kay Seden, et al.. (2013). Use of a physiologically-based pharmacokinetic model to simulate artemether dose adjustment for overcoming the drug-drug interaction with efavirenz. In Silico Pharmacology. 1(1). 4–4. 25 indexed citations
11.
Seden, Kay, et al.. (2013). The clinical utility of HIV outpatient pharmacist prescreening to reduce medication error and assess adherence. International Journal of STD & AIDS. 24(3). 237–241. 14 indexed citations
12.
Seden, Kay, Happy Mathew Tirivangasi, Matthew J. Bradley, et al.. (2012). Patients accessing HIV treatment via sexual health services: what are the risks of the dual case-note system?. International Journal of STD & AIDS. 23(2). 99–104. 3 indexed citations
13.
Seden, Kay, Saye Khoo, David Back, et al.. (2012). Global patient safety and antiretroviral drug-drug interactions in the resource-limited setting. Journal of Antimicrobial Chemotherapy. 68(1). 1–3. 16 indexed citations
14.
Seden, Kay, Catherine L.R. Merry, Mohammed Lamorde, et al.. (2012). Prevalence and type of drug‐drug interactions involving antiretrovirals in patients attending a specialist outpatient clinic in Kampala, Uganda. Journal of the International AIDS Society. 15(S4). 1–1. 2 indexed citations
15.
Seden, Kay & David Back. (2011). Directly acting antivirals for hepatitis C and antiretrovirals. Current Opinion in HIV and AIDS. 6(6). 514–526. 31 indexed citations
16.
Kigen, Gabriel, Sylvester Kimaiyo, Winstone Nyandiko, et al.. (2011). Prevalence of Potential Drug-Drug Interactions Involving Antiretroviral Drugs in a Large Kenyan Cohort. PLoS ONE. 6(2). e16800–e16800. 35 indexed citations
17.
Seden, Kay, Laura Dickinson, Saye Khoo, & David Back. (2010). Grapefruit-Drug Interactions. Drugs. 70(18). 2373–2407. 102 indexed citations
18.
Seden, Kay, David Back, & Saye Khoo. (2010). New directly acting antivirals for hepatitis C: potential for interaction with antiretrovirals. Journal of Antimicrobial Chemotherapy. 65(6). 1079–1085. 48 indexed citations
19.
Seden, Kay, DJ Back, & SH Khoo. (2010). Evaluating pharmacist involvement in HIV outpatient clinics: can medication histories, drug interaction checks and adherence assessments add benefit?. Journal of the International AIDS Society. 13(S4). 1 indexed citations
20.
Seden, Kay, D.J. Back, & SH Khoo. (2009). Antiretroviral drug interactions: often unrecognized, frequently unavoidable, sometimes unmanageable. Journal of Antimicrobial Chemotherapy. 64(1). 5–8. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nancy L. Sheehan Breakdown of academic impact, for papers by Annemie Stewart Breakdown of academic impact, for papers by Monique M. R. de Maat Breakdown of academic impact, for papers by Amanda Corbett Breakdown of academic impact, for papers by Cary R. Chrisman Breakdown of academic impact, for papers by Charles la Porte Breakdown of academic impact, for papers by Willem L. Blok Breakdown of academic impact, for papers by Marc Blockman Breakdown of academic impact, for papers by Sara Baldelli Breakdown of academic impact, for papers by Cornelis H.W. Koks
Rankless by CCL
2026